Postoperative NSCLC Treated With Integrated Medicine Base on Circulating Tumor Cell Detection
Status:
Unknown status
Trial end date:
2019-09-30
Target enrollment:
Participant gender:
Summary
Objective: To study the effect of Jinfukang Koufuye combined with chemotherapy on preventing
relapse and metastasis of early postoperative NSCLC patients. Method: In this
multicenter、prospective、randomized controlled clinical trial, 144 NSCLC patients with
complete resection、stage Ib-IIb were randomly divided into Jinfukang Koufuye combined with
chemotherapy group (treatment group, N=72) and chemotherapy only group (controlled group,
N=72). Peripheral blood CTCs and immune cells were detect on five different time points:
after operation、4 chemotherapy cycles were over、12 months after operation、18 months after
operation、and 24 months after operation. To evaluate the effect of Jinfukang Koufuye combined
with chemotherapy on the level of peripheral blood CTCs、DFS、immune function、quality of life
of postoperative patients; and decreasing the side effect of chemotherapy.